bluebird bio Inc.(BLUE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BLUE bluebird bio Inc.

已收盘 11-18 16:00:00 EST

0.3330

+0.0122

+3.80%

盘后0.3241

-0.0089-2.67%

19:52 EST

最高0.3365	最低0.3150	成交量356.01万
今开0.3241	昨收0.3208	日振幅6.70%
总市值6,475万	流通市值6,445万	总股本1.94亿
成交额116.51万	换手率1.84%	流通股本1.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BLUE","market":"US","secType":"STK","nameCN":"bluebird bio Inc.","latestPrice":0.333,"timestamp":1731963600000,"preClose":0.3208,"halted":0,"volume":3560083,"hourTrading":{"tag":"盘后","latestPrice":0.3241,"preClose":0.333,"latestTime":"19:52 EST","volume":15830,"amount":5159.6751,"timestamp":1731977532306},"delay":0,"floatShares":193542376,"shares":194444345,"eps":-1.678226,"marketStatus":"已收盘","marketStatusCode":5,"change":0.0122,"latestTime":"11-18 16:00:00 EST","open":0.3241,"high":0.3365,"low":0.315,"amount":1165119.93367975,"amplitude":0.06702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.678226,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1371614400000,"adjPreClose":0.3208,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.3275,"preClose":0.3208,"latestTime":"09:28 EST","volume":14512,"amount":4707.4475471999995,"timestamp":1731940133944},"postHourTrading":{"tag":"盘后","latestPrice":0.3241,"preClose":0.333,"latestTime":"19:52 EST","volume":15830,"amount":5159.6751,"timestamp":1731977532306},"volumeRatio":0.554264,"impliedVol":3.6613,"impliedVolPercentile":0.9761},"requestUrl":"/m/hq/s/BLUE","defaultTab":"news","newsList":[{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AESI","AIN","AHR","BK4534","BTM","BJ","BRZE","LNG","LU1074936037.SGD","BMY","BIIB","LU1032466523.USD","AMH","LU1267930227.SGD","LU0868494708.USD","LU0354030511.USD","AAL","AHCO","ASND","AFG","IE00BBT3K403.USD","AMAT","ALK","CAVA","CELC","BRX","CABA","AGYS","AAP","BE","CHX","AGCO","ARI","BK4588","AKYA","BAC","SCHW","APH","BKR","BV","ASTS","BLUE","ALGT","IE00BKVL7J92.USD","BL","ADSK","AROC","LU1861217088.USD","ASB","ARE"],"gpt_icon":1},{"id":"2483018233","title":"BUZZ-蓝鸟第三季度营收不及预期，评级遭下调","url":"https://stock-news.laohu8.com/highlight/detail?id=2483018233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483018233?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:25","pubTimestamp":1731687908,"startTime":"0","endTime":"0","summary":"    11月15日 - ** 基因疗法开发商蓝鸟生物公司  股价下跌约10%，创下32美分的历史新低** 周四，该公司发布  第三季度销售额为 1060 万美元，低于分析师预计的 1810 万美元--LSEG 数据** 美国银行全球研究 将 BLUE 的评级从 \"买入 \"下调至 \"中性\"，并将该公司镰状细胞疾病基因疗法 Lyfgenia 的最高收入预期从 7.3 亿美元下调至 5.4 亿美元。** 经纪公司还将该公司 2025 年的收入预期从约 1.9 亿美元下调至 1.5 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE"],"gpt_icon":0},{"id":"2483722603","title":"蓝鸟生物盘中异动 早盘大幅下挫5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483722603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483722603?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:35","pubTimestamp":1731681329,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时35分，蓝鸟生物股票出现异动，股价大幅下挫5.13%。截至发稿，该股报0.344美元/股，成交量39.9431万股，换手率0.21%，振幅6.70%。蓝鸟生物股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2825.18%、186.26%、117.43%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.，振幅分别为114.92%、97.30%、61.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223529971a6d3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115223529971a6d3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4578","BLUE"],"gpt_icon":0},{"id":"2483804815","title":"蓝鸟生物盘中异动 早盘股价大跌6.99%报0.350美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483804815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483804815?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:40","pubTimestamp":1731595211,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时40分，蓝鸟生物股票出现波动，股价急速下挫6.99%。截至发稿，该股报0.350美元/股，成交量51.8256万股，换手率0.27%，振幅4.62%。最近的财报数据显示，该股实现营业收入16.10百万美元，净利润-81.39百万美元，每股收益-0.42美元，毛利-12.85百万美元，市盈率-0.16倍。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224011a237d70a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224011a237d70a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4139","ELAB","BK4183","BK4578","BK4556"],"gpt_icon":0},{"id":"2483882674","title":"蓝鸟生物盘中异动 股价大涨5.99%报0.414美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483882674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483882674?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:52","pubTimestamp":1731509543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时52分，蓝鸟生物股票出现异动，股价急速拉升5.99%。截至发稿，该股报0.414美元/股，成交量36.0885万股，换手率0.19%，振幅6.14%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Lexeo Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为357.11%、209.29%、91.38%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Immunoprecise Antibodies Ltd.，振幅分别为44.21%、36.31%、26.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225223971a64df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113225223971a64df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BLUE","BK4578","BK4139"],"gpt_icon":0},{"id":"2482089976","title":"蓝鸟生物盘中异动 大幅上涨5.13%报0.426美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482089976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482089976?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:02","pubTimestamp":1731423750,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时02分，蓝鸟生物股票出现异动，股价急速上涨5.13%。截至发稿，该股报0.426美元/股，成交量71.6945万股，换手率0.37%，振幅5.58%。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Cero Therapeutics Holdings, Inc.、Geovax Labs, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为172.49%、154.75%、105.42%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为65.13%、49.39%、34.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230230a230cd34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112230230a230cd34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4578","BLUE","BK4556"],"gpt_icon":0},{"id":"2482071417","title":"蓝鸟生物  预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482071417","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482071417?lang=zh_cn&edition=full","pubTime":"2024-11-12 21:55","pubTimestamp":1731419715,"startTime":"0","endTime":"0","summary":"   * 蓝鸟生物公司   将于11月14日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。* LSEG分析师对蓝鸟生物公司的平均预期是每股亏损36美分。* 华尔街对蓝鸟生物公司 12 个月目标价的中位数为 2.50 美元，高于上一交易日 0.41 美元的收盘价。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"蓝鸟生物  预计每股亏损36美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE"],"gpt_icon":0},{"id":"2482737379","title":"蓝鸟生物盘中异动 早盘股价大涨5.10%报0.426美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482737379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482737379?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:24","pubTimestamp":1731342264,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时24分，蓝鸟生物股票出现异动，股价快速拉升5.10%。截至发稿，该股报0.426美元/股，成交量199.741万股，换手率1.03%，振幅6.88%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为619.65%、479.70%、185.84%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为123.43%、72.42%、61.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112002425a22d2044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112002425a22d2044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4578","BK4556","BLUE"],"gpt_icon":0},{"id":"2481348817","title":"蓝鸟生物盘中异动 股价大涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481348817","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481348817?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:33","pubTimestamp":1731080014,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时33分，蓝鸟生物股票出现异动，股价急速拉升5.47%。截至发稿，该股报0.403美元/股，成交量174.649万股，换手率0.90%，振幅5.23%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为592.03%、49.80%、46.97%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为86.00%、72.78%、31.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108233334a224e712&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108233334a224e712&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4556","BK4139"],"gpt_icon":0},{"id":"2481898871","title":"蓝鸟生物盘中异动 早盘快速下挫5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481898871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481898871?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989879,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时31分，蓝鸟生物股票出现波动，股价急速下跌5.55%。截至发稿，该股报0.415美元/股，成交量30.8229万股，换手率0.16%，振幅0.57%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Ensysce Biosciences, Inc.、Mustang Bio, Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为76.92%、54.48%、47.54%，振幅较大的相关个股有Tuhura Biosciences, Inc.、Immunic, Inc.、Fennec Pharmaceuticals Inc.，振幅分别为8.54%、5.93%、4.85%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223124a220ec3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107223124a220ec3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4578","BLUE","BK4556"],"gpt_icon":0},{"id":"2481899596","title":"BUZZ-早期试验中患者死亡，Beam Therapeutics 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481899596?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:40","pubTimestamp":1730821201,"startTime":"0","endTime":"0","summary":"    11月5日 - ** 生物技术公司Beam Therapeutics   股价下跌3.30%，至23.56美元** 摘要显示，在该公司基于CRISPR技术的细胞疗法BEAM-101的早中期试验中，一名镰状细胞病患者因呼吸衰竭死亡。** Vertex  和CRISPR Therapeutics的  Casgevy和蓝鸟生物的  Lyfgenia被批准用于治疗镰状细胞病，这是一组遗传性血液疾病。** BEAM 第三季度净亏损为 9,670 万美元，合每股亏损 1.17 美元，去年同期净亏损为 9,610 万美元，合每股亏损 1.22 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","BK4532","BK4588","LU2362541513.USD","IE0002270589.USD","IE0002141913.USD","BK4505","LU0058720904.USD","VRTX","BK4585","LU0079474960.USD","LU2237438978.USD","BK4567","IE00BJJMRZ35.SGD","BK4556","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1093756168.USD","IE00BZ9MQY76.HKD","BK4535","LU0256863811.USD","LENZ","LU1585245621.USD","LU2456880835.USD","IE0009355771.USD","IE00B19Z9P08.USD","LU0823416689.USD","BK4139","IE00B19Z9Z06.USD","LU0289739699.SGD","LU2324357040.USD","BLUE","LU0889565916.HKD","IE00B19Z3581.USD","LU0061475181.USD","LU1430594728.SGD","LU2362540622.SGD","LU2417539215.USD","LU2462157665.USD","LU2236285917.USD","LU0417517546.SGD","LU1093756325.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU0234570918.USD","IE00BJT1NW94.SGD","BK4578","IE00B19Z3B42.SGD","BK4533"],"gpt_icon":0},{"id":"2480882704","title":"蓝鸟生物  预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480882704","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480882704?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:33","pubTimestamp":1730471591,"startTime":"0","endTime":"0","summary":"   * 蓝鸟生物公司   预计在11月5日公布截至2024年9月30日的业绩报告时将显示季度收入增长(预计)    * 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于马萨诸塞州萨默维尔的公司的营收预计将从去年同期的1239万美元增长45.6%，达到1804.9万美元。* LSEG分析师对蓝鸟生物公司的平均预期是每股亏损36美分。* 华尔街对蓝鸟生物公司 12 个月目标价的中位数为 2.50 美元，高于上一交易日 0.46 美元的收盘价。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"蓝鸟生物  预计每股亏损36美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE"],"gpt_icon":0},{"id":"2480063596","title":"蓝鸟生物盘中异动 下午盘股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480063596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480063596?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:22","pubTimestamp":1730402566,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时22分，蓝鸟生物股票出现异动，股价急速下跌5.67%。截至发稿，该股报0.461美元/股，成交量300.81万股，换手率1.55%，振幅6.08%。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为3.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103224698e3fc99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110103224698e3fc99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4578","BLUE"],"gpt_icon":0},{"id":"2478484420","title":"蓝鸟生物盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478484420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478484420?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:16","pubTimestamp":1730124994,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时16分，蓝鸟生物股票出现波动，股价快速拉升5.08%。截至发稿，该股报0.505美元/股，成交量83.561万股，换手率0.43%，振幅4.64%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为624.42%、52.98%、51.93%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.，振幅分别为87.13%、84.14%、46.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221634ab7bdd43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221634ab7bdd43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4578","BK4139"],"gpt_icon":0},{"id":"2477554206","title":"蓝鸟生物盘中异动 早盘股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477554206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477554206?lang=zh_cn&edition=full","pubTime":"2024-10-24 23:16","pubTimestamp":1729783012,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日23时16分，蓝鸟生物股票出现波动，股价急速下挫5.40%。截至发稿，该股报0.485美元/股，成交量129.555万股，换手率0.67%，振幅5.62%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dbv Technologies涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为249.73%、170.60%、123.56%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为77.83%、71.78%、60.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231653971a21a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024231653971a21a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4139","BLUE","BK4556"],"gpt_icon":0},{"id":"2475585333","title":"基因疗法第一网红，翻盘越来越难了","url":"https://stock-news.laohu8.com/highlight/detail?id=2475585333","media":"氨基观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475585333?lang=zh_cn&edition=full","pubTime":"2024-10-14 15:01","pubTimestamp":1728889310,"startTime":"0","endTime":"0","summary":"1999年，一名18岁少年在接受腺病毒基因疗法后发生严重免疫反应死亡，这是第一例因基因疗法而死亡的患者。这一事件，也使得FDA收紧了对于基因疗法的临床审批，基因疗法因此沉寂了十余年之久。基因疗法得以再度活跃。不过，安全问题并未随着基因疗法获批上市而消失。2020年8月，被安斯泰来30亿美元收购的基因疗法公司Audentes，其核心产品AT132在临床试验中出现了三位患者死亡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101415020195a60d1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101415020195a60d1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4556","BK4139"],"gpt_icon":0},{"id":"2474405732","title":"蓝鸟生物盘中异动 股价大跌5.67%报0.491美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474405732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474405732?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:55","pubTimestamp":1728406536,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时55分，蓝鸟生物股票出现波动，股价大幅下跌5.67%。截至发稿，该股报0.491美元/股，成交量372.141万股，换手率1.92%，振幅4.76%。最近的财报数据显示，该股实现营业收入16.10百万美元，净利润-81.39百万美元，每股收益-0.42美元，毛利-12.85百万美元，市盈率-0.22倍。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090055369719f045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090055369719f045&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4556","BK4139","BK4578"],"gpt_icon":0},{"id":"2473910521","title":"蓝鸟生物盘中异动 早盘快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473910521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473910521?lang=zh_cn&edition=full","pubTime":"2024-10-07 21:37","pubTimestamp":1728308220,"startTime":"0","endTime":"0","summary":"北京时间2024年10月07日21时37分，蓝鸟生物股票出现波动，股价急速下挫5.09%。截至发稿，该股报0.541美元/股，成交量38.2016万股，换手率0.20%，振幅4.72%。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721370098e3ad8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100721370098e3ad8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BLUE","BK4139","BK4578"],"gpt_icon":0},{"id":"2472952760","title":"蓝鸟生物盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952760?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:44","pubTimestamp":1728049475,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时44分，蓝鸟生物股票出现异动，股价快速上涨5.19%。截至发稿，该股报0.545美元/股，成交量22.1915万股，换手率0.11%，振幅3.32%。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.26%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421443598e3a98c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100421443598e3a98c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4556","BK4139"],"gpt_icon":0},{"id":"2472050897","title":"蓝鸟生物盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472050897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472050897?lang=zh_cn&edition=full","pubTime":"2024-10-03 02:41","pubTimestamp":1727894499,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日02时41分，蓝鸟生物股票出现异动，股价急速上涨5.04%。截至发稿，该股报0.494美元/股，成交量647.552万股，换手率3.34%，振幅8.69%。机构评级方面，在所有10家参与评级的机构中，30%的券商给予买入建议，60%的券商给予持有建议，10%的券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.99%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003024139ab677c73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003024139ab677c73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","BK4578","BLUE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bluebirdbio.com","stockEarnings":[{"period":"1week","weight":-0.2093},{"period":"1month","weight":-0.3342},{"period":"3month","weight":-0.5476},{"period":"6month","weight":-0.6885},{"period":"1year","weight":-0.8945},{"period":"ytd","weight":-0.7675}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"bluebird bio, Inc.于1992年4月16日在特拉华州注册成立。该公司的成立是为了开发、制造和销售治疗方法，以安全有效地传递可用于治疗严重人类疾病的基因。他们专注于基于其专有的慢病毒载体（“LVV”）基因添加平台，研究、开发和商业化治疗严重遗传病的潜在治愈性基因疗法。他们目前在美国销售三种基因疗法：ZYNTEGLO（betibeglogene autoemcel，也称为beti-cel）和SKYSONA（elivaltogene autoemcel），于2022年获得美国食品和药物管理局（“FDA”）的批准，以及LYFGENIA（lovotibegogene autoemcl，也称为lovo cel），已于2023年12月获得美国食品药品监督管理局的批准。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":-0.018091},{"month":2,"riseRate":0.545455,"avgChangeRate":0.015212},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.0983},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.011785},{"month":5,"riseRate":0.636364,"avgChangeRate":0.025424},{"month":6,"riseRate":0.545455,"avgChangeRate":0.106851},{"month":7,"riseRate":0.416667,"avgChangeRate":0.039553},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.046336},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.031496},{"month":10,"riseRate":0.25,"avgChangeRate":-0.059779},{"month":11,"riseRate":0.5,"avgChangeRate":0.015294},{"month":12,"riseRate":0.454545,"avgChangeRate":0.012649}],"exchange":"NASDAQ","name":"bluebird bio Inc.","nameEN":"bluebird bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"bluebird bio Inc.(BLUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供bluebird bio Inc.(BLUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"bluebird bio Inc.,BLUE,bluebird bio Inc.股票,bluebird bio Inc.股票老虎,bluebird bio Inc.股票老虎国际,bluebird bio Inc.行情,bluebird bio Inc.股票行情,bluebird bio Inc.股价,bluebird bio Inc.股市,bluebird bio Inc.股票价格,bluebird bio Inc.股票交易,bluebird bio Inc.股票购买,bluebird bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"bluebird bio Inc.(BLUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供bluebird bio Inc.(BLUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}